612(top 1%)
papers
31.0K(top 1%)
citations
80(top 1%)
h-index
163(top 0.1%)
g-index
655
all documents
33.1K
doc citations
3.9K
citing journals

Top Articles

#TitleJournalYearCitations
1Optical properties of biological tissues: a reviewPhysics in Medicine and Biology20132,743
2Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel ReportJournal of Allergy and Clinical Immunology20101,614
3Guidelines of care for the management of atopic dermatitisJournal of the American Academy of Dermatology2014970
4The eczema area and severity index (EASI): assessment of reliability in atopic dermatitisExperimental Dermatology2001897
5Guidelines of care for the management of atopic dermatitisJournal of the American Academy of Dermatology2014889
6Guidelines of care for the management of atopic dermatitisJournal of the American Academy of Dermatology2014695
7CIP2A Inhibits PP2A in Human MalignanciesCell2007662
8Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's HealthJournal of Investigative Dermatology2011612
9Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis preventionJournal of Allergy and Clinical Immunology2014594
10Circulating Th17, Th22, and Th1 Cells Are Increased in PsoriasisJournal of Investigative Dermatology2010522
11Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trialLancet, The2016471
12Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis PathogenesisJournal of Investigative Dermatology2009410
13Gene for Familial Psoriasis Susceptibility Mapped to the Distal End of Human Chromosome 17qScience1994403
14Guidelines of care for the management of primary cutaneous melanomaJournal of the American Academy of Dermatology2019400
15Consensus Statement on Diagnostic Criteria for PHACE SyndromePediatrics2009361
16Mental health comorbidity in patients with atopic dermatitisJournal of Allergy and Clinical Immunology2013360
17Recombinant interferon gamma therapy for atopic dermatitisJournal of the American Academy of Dermatology1993288
18Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrialsBritish Journal of Dermatology2020277
19Melanocytes as Instigators and Victims of Oxidative StressJournal of Investigative Dermatology2014270
20Substance P selectively activates TNF-alpha gene expression in murine mast cells.Journal of Immunology1993268
21Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre surveyBritish Journal of Dermatology1998267
22Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adultsJournal of the American Academy of Dermatology2016251
23Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose studyJournal of the American Academy of Dermatology2019249
24Substance P selectively activates TNF-alpha gene expression in murine mast cellsJournal of Immunology1993231
25Cellular origin of the dermal-epidermal basement membraneDevelopmental Dynamics1993222
26Elevated leukocyte cyclic AMP—phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP—agonist hyporesponsivenessJournal of Allergy and Clinical Immunology1982217
27IL-23–Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17AJournal of Immunology2011212
28Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomised, double-blind, placebo-controlled, phase II regimen-finding studyBritish Journal of Dermatology2012199
29Type 4 Phosphodiesterase Inhibitors Have Clinical and In Vitro Anti-inflammatory Effects in Atopic DermatitisJournal of Investigative Dermatology1996195
30Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension studyJournal of Allergy and Clinical Immunology2018195
31Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic DermatitisJAMA Dermatology2020194
32IL-23 and IL-17A, but Not IL-12 and IL-22, Are Required for Optimal Skin Host Defense against Candida albicansJournal of Immunology2010193
33Persistence of atopic dermatitis (AD): A systematic review and meta-analysisJournal of the American Academy of Dermatology2016186
34Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trialLancet, The2020178
35When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema CouncilJournal of the American Academy of Dermatology2017170
36Atopic dermatitis in the pediatric populationAnnals of Allergy, Asthma and Immunology2021170
37A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: Many options, no standardsJournal of the American Academy of Dermatology2016162
38A pilot study of emollient therapy for the primary prevention of atopic dermatitisJournal of the American Academy of Dermatology2010161
39Eosinophilic Pustular Folliculitis In InfancyPediatric Dermatology1984158
40The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-coBritish Journal of Dermatology2016157
41Amelanotic melanoma: The great masqueraderJournal of the American Academy of Dermatology2000156
42SUPPRESSED CELL-MEDIATED IMMUNITY IN TWO ADULTS WITH ATOPIC DERMATITISBritish Journal of Dermatology1972155
43Risk for PHACE Syndrome in Infants With Large Facial HemangiomasPediatrics2010155
44Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticumJournal of Allergy and Clinical Immunology2010149
45Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cyclesJournal of the American Academy of Dermatology2010148
46Prevalence and relevance of allergic reactions in patients patch tested in North America—1984 to 1985Journal of the American Academy of Dermatology1989138
47T-Helper 17 Cells in Psoriatic Plaques and Additional Genetic Links between IL-23 and PsoriasisJournal of Investigative Dermatology2008138
48Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programmeBritish Journal of Dermatology2004136
49Immunological reactivity in dermatophytosisBritish Journal of Dermatology2006134
50Tumor-initiating cells establish an IL-33–TGF-β niche signaling loop to promote cancer progressionScience2020134